Osmotica Pharmaceuticals PLC at Barclays Global Healthcare Conference Transcript
You may begin.
Thank you, operator, and good morning. This is Brian Markison, CEO of Osmotica Pharmaceuticals. With me today is also Andrew Einhorn, our Chief Financial Officer, and we'd like to welcome you to our Investor Presentation, virtually.
So the presentation that I will be reviewing with you will be available and is available on our website, and we'll be -- I'll be referencing the page numbers that are on the presentation as we go through it.
So on the second page of our presentation, and please note the safe harbor. I won't read it, but it's there on Page #2.
Page #3 basically describes Osmotica is a fully integrated and diversified pharmaceutical company. We have development and commercialization expertise, and we participate in a number of target markets.
Slide #4, Osmotica Corporate Strategy. We're embarking on a journey where we are leveraging our core capability. We have a number of near-term exciting pipeline opportunities, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
